Back to Search
Start Over
<scp>Cost‐effectiveness</scp> of omalizumab for the treatment of severe pediatric allergic asthma—Results of a <scp>real‐life</scp> study in Spain
- Source :
- Pediatric Allergy and Immunology. 34
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Immunology
Pediatrics, Perinatology and Child Health
Immunology and Allergy
Subjects
Details
- ISSN :
- 13993038 and 09056157
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Pediatric Allergy and Immunology
- Accession number :
- edsair.doi...........ca1ee21b1b1f220a8c6509c8ec7cf4c8